GlassScriptPhysician profile
George Philip
NPI 1639312242
$35,610.82
in general payments reported to CMS, 2019-2025
14 companies · $1,951 in 2025
The $1,951 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,986 · 2020: $431 · 2021: $3,010 · 2022: $5,307 · 2023: $19K · 2025: $1,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Education: $6,000 · Travel and Lodging: $3,141 · Food and Beverage: $1,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,400.00 |
| Education | $6,000.00 |
| Travel and Lodging | $3,140.77 |
| Food and Beverage | $1,336.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $18,379.73 | 2021-2023 | Matrixrib |
| Intuitive Surgical, INC. | $14,043.93 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $1,557.48 | 2021-2022 | |
| Depuy Synthes Sales INC. | $764.12 | 2021-2025 | Matrixrib, Trumatch |
| Kls-Martin L.P. | $318.20 | 2021-2025 | |
| Atricure, INC. | $151.55 | 2021-2023 | |
| Kerecis Limited | $147.04 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $79.15 | 2023 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Takeda Pharmaceuticals U.S.A., INC. | $61.78 | 2022-2023 | Entyvio |
| Polynovo North America LLC | $35.98 | 2022 | |
| Conetic Solutions, INC. | $19.15 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.05 | 2022 | |
| Genzyme Corporation | $18.18 | 2023 | |
| Ferring Pharmaceuticals INC. | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Philip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.